Alkermes plc (ALKS) said to prevail in Luya Pharma IPR challenge

November 30, 2016 1:40 PM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Alkermes plc (NASDAQ: ALKS) said to prevail in Luya Pharma IPR challenge related to '061 patent.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Litigation

Add Your Comment